baseline characteristics of the trial participants, according to study group* - part i
DESCRIPTION
Baseline Characteristics of the Trial Participants, According to Study Group* - Part I. PM Ridker, et al. N Engl J Med 2008;359:2195-207. Baseline Characteristics of the Trial Participants, According to Study Group* - Part II. PM Ridker, et al. N Engl J Med 2008;359:2195-207. - PowerPoint PPT PresentationTRANSCRIPT
Baseline Characteristics of the Trial Participants, According to Study Group* - Part I
PM Ridker, et al. N Engl J Med 2008;359:2195-207
Baseline Characteristics of the Trial Participants, According to Study Group* - Part II
PM Ridker, et al. N Engl J Med 2008;359:2195-207
Lipid and High-Sensitivity C-Reactive Protein Levels during the Follow-up Period, According to Study Group*
PM Ridker, et al. N Engl J Med 2008;359:2195-207
Outcomes According to Study Group
PM Ridker, et al. N Engl J Med 2008;359:2195-207
Cumulative Incidence of Cardiovascular Events According to Study Group
PM Ridker, et al. N Engl J Med 2008;359:2195-207
Effects of Rosuvastatin on the Primary End Point, According to Baseline Characteristics
PM Ridker, et al. N Engl J Med 2008;359:2195-207
Monitored Adverse Events, Measured Laboratory Values, and Other Reported Events of Interest during the Follow-up Period*
PM Ridker, et al. N Engl J Med 2008;359:2195-207
Trial schematic
PM Ridker, et al. N Engl J Med 2008;359:2195-207 - Online Supplemental Appendix
Relationship of the proportional reduction in cardiovascular event rate and mean LDL cholesterol difference between
treatment groups in published statin trials
PM Ridker, et al. N Engl J Med 2008;359:2195-207 - Online Supplemental Appendix